Markets
Baskets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Price History/Seasonality
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Aurobindo Pharma Ltd.
NSE: AUROPHARMA
|
BSE: 524804
|
ISIN: INE406A01037
|
Industry: Pharmaceuticals
US FDA Observation
|
Turnaround Potential
1195.4000
-15.00
(
-1.24
%)
NSE
Mar 04, 2026
15:52 PM
Volume:
909.7K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Aurobindo Pharma Ltd.
29 May 2023
US FDA Observation
1195.40
-1.24%
Aurobindo Pharma Limited
Hold:
Aurobindo Pharma Ltd.
by
ICICI Direct
Target: 615
Target
ICICI Direct
Aurobindo Pharma Ltd. has an
average target
of 1332.89 from 9 brokers.
More from Aurobindo Pharma Ltd.
Recommended
Market closes lower as Indian rupee hits record low amid Middle East tensions
Trendlyne Marketwatch |
04 Mar 2026, 03:54PM
Bad timing: New listings sink on debut amid market turmoil
|
02 Mar 2026, 05:29PM
A deal is called off, increasing the chance for Aurobindo Pharma to be debt free
|
15 Jul 2020